SEC Form D · filed January 13, 2021
GeneCentric Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Myla V. Lai-Goldman · Durham, NCExec · DirectorEllen V. Lubman · Durham, NCDirectorArnold V. Levine · Durham, NCDirectorClay V. Thorp · Durham, NCDirectorMichael V. Milburn · Durham, NCExec · DirectorCharles Perou · DURHAM, NCExec · DirectorBrad Buscher · Aurora, CODirectorDeborah Wittman · Aurora, CODirectorDavid Bostwick · Aurora, COExec · DirectorMichael Montag · Aurora, COExec · DirectorJohn Harper · Aurora, CODirectorAndrew Dodge · New York, NYDirectorErrik Anderson · Boston, MADirectorDonald A. Holzworth · Greenwood Village, COExec · DirectorPamela J. Pure · Greenwood Village, COExec · DirectorDylan L. Pure · Greenwood Village, CODirectorCharles Perou · DURHAM, NCExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗